Similar articles for PMID: 26152440

Year	Number of Results
1996	1
1998	1
2000	1
2001	1
2006	3
2007	1
2008	5
2009	5
2010	5
2011	8
2012	13
2013	16
2014	12
2015	18
2016	29
2017	33
2018	36
2019	15
2020	16
2021	13
2022	4

1

Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations.

Li J, Berkowitz Z, Hall IJ. Li J, et al. J Am Board Fam Med. 2015 Jul-Aug;28(4):491-3. doi: 10.3122/jabfm.2015.04.150062. J Am Board Fam Med. 2015. PMID: 26152440 Free PMC article.

2

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.

Drazer MW, Huo D, Eggener SE. Drazer MW, et al. J Clin Oncol. 2015 Aug 1;33(22):2416-23. doi: 10.1200/JCO.2015.61.6532. Epub 2015 Jun 8. J Clin Oncol. 2015. PMID: 26056181

3

Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.

Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O, Ward EM. Jemal A, et al. JAMA. 2015 Nov 17;314(19):2054-61. doi: 10.1001/jama.2015.14905. JAMA. 2015. PMID: 26575061

4

Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.

Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire MS, Helfand BT. Cohn JA, et al. Urol Oncol. 2014 Jan;32(1):41.e23-30. doi: 10.1016/j.urolonc.2013.04.013. Epub 2013 Aug 2. Urol Oncol. 2014. PMID: 23911680

5

The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.

Zargar H, van den Bergh R, Moon D, Lawrentschuk N, Costello A, Murphy D. Zargar H, et al. BJU Int. 2017 Jan;119(1):110-115. doi: 10.1111/bju.13602. Epub 2016 Aug 22. BJU Int. 2017. PMID: 27454454

6

State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.

Vetterlein MW, Dalela D, Sammon JD, Karabon P, Sood A, Jindal T, Meyer CP, Löppenberg B, Sun M, Trinh QD, Menon M, Abdollah F. Vetterlein MW, et al. Urology. 2018 Feb;112:56-65. doi: 10.1016/j.urology.2017.08.055. Epub 2017 Oct 19. Urology. 2018. PMID: 29056579

7

Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.

Frendl DM, Epstein MM, Fouayzi H, Krajenta R, Rybicki BA, Sokoloff MH. Frendl DM, et al. Cancer Causes Control. 2020 Sep;31(9):861-867. doi: 10.1007/s10552-020-01324-x. Epub 2020 Jun 17. Cancer Causes Control. 2020. PMID: 32556947 Free PMC article.

8

Prostate cancer screening practices in a large, integrated health system: 2007-2014.

Misra-Hebert AD, Hu B, Klein EA, Stephenson A, Taksler GB, Kattan MW, Rothberg MB. Misra-Hebert AD, et al. BJU Int. 2017 Aug;120(2):257-264. doi: 10.1111/bju.13793. Epub 2017 Feb 26. BJU Int. 2017. PMID: 28139034 Free PMC article.

9

US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses.

Gejerman G, Ciccone P, Goldstein M, Lanteri V, Schlecker B, Sanzone J, Esposito M, Rome S, Ciccone M, Margolis E, Simon R, Guo Y, Pentakota SR, Sadeghi-Nejad H. Gejerman G, et al. Investig Clin Urol. 2017 Nov;58(6):423-428. doi: 10.4111/icu.2017.58.6.423. Epub 2017 Nov 2. Investig Clin Urol. 2017. PMID: 29124241 Free PMC article.

10

PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.

Kearns JT, Holt SK, Wright JL, Lin DW, Lange PH, Gore JL. Kearns JT, et al. Cancer. 2018 Jul 1;124(13):2733-2739. doi: 10.1002/cncr.31337. Epub 2018 May 21. Cancer. 2018. PMID: 29781117 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed